Clinical Trial

Study of SC-102 in Patients With Advanced Solid Tumors

Name: Study of SC-102 in Patients With Advanced Solid Tumors — clinical trial record (NCT06710158)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety, PK profile, and anti-cancer efficacy of SC-102 in subjects with advanced solid tumors

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-11-25; most recent amendment 2025-07-28.

Status change: Not Yet Recruiting → Recruiting 2025-04-07

Trial Details

NCT Number	NCT06710158
Lead Sponsor	Tianjin ConjuStar Biologics Co., Ltd.
Conditions	Advanced Solid Cancers
Enrollment	120 participants
Start Date	2024-12-05
Primary Completion	2026-12 (estimated)
Study Completion	2027-06 (estimated)
Updated on ClinicalTrials.gov	2025-07-29